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Abstract
The potential relationships between biofilm formation and pathogenicity of Enterococcus fae-
calis in urinary tract infections (UTI) were investigated. Over a 12-year period from 1991 through
2002, a total of 352 E.faecalis isolates were collected from patients with complicated UTI (one iso-
late per patient) at the urology ward of Okayama University Hospital. We analyzed the prevalence
and transferability of genes encoding virulence factors(asa1, esp, cylA, gelE /sprE )and antimi-
crobial resistance(aac(6’) /aph(2”)). The production of biofilm, hemolysin and gelatinase by these
isolates was also examined and the associated medical records of patients were retrospectively
reviewed. Of 352 E. faecalis isolates, 315 possessed and/or genes. Of the 63 hemolysin- and 167
gelatinase-producing isolates, 59 and 94 isolates, respectively, possessed both asa1 and esp genes.
E. faecalis isolates with both asa1 and esp genes formed biofilms at significantly higher rates than
those with neither gene (P=0.038). The genes encoding asa1, cylA , and aac(6’) /(aph(2”) were
transferable and appeared to have accumulated in these isolates. The E. faecalis isolates possess-
ing asa1 and/or esp genes were found from both catheter-related or -unrelated UTI. Our study
indicates that E. faecalis isolates that have accumulated virulence genes are apt to form persistent
biofilms in the urinary tracts.
KEYWORDS: Enterococcus faecalis, urinary tract infection, biofilm formation, pathogenicity,
gene transfer
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nterococcus faecalis is a normal commensal in the human intestinal ﬂora but can lead to nosocomial infections［1-5］. Although the pathogenicity of E.
faecalis in the urinary tract is not considered high, E.
faecalis has been isolated from the urinary tract at increas-
ing frequencies:up to 20  of urinary isolates in some reports［6-8］. Several virulence factors have been described in E. faecalis, including aggregation substance
(Agg), enterococcal surface protein(Esp), cytolysi
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lytic and bactericidal activity, and gelatinase (Gel)［1, 3, 4］. These factors have been thought to act synergistically to enhance virulence by facilitating achievement of a quorum and activating the quorum-sensing mode of regulation, resulting in tissue damage and potentially deeper tissue invasion［1, 9-12］.
Recent studies have shown that ent
 
omone-responsive E. fa
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ecalis plasmids［18, 19］. It is produced in response to pher-
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and causes the aggregation of donor and recipient cells,
thereby facilitating the transfer of plasmids that may carry virulence traits and antibiotic resistance genes［18, 19］.
Agg may also play an important role in the onset of enterococcal infection by facilitating the adherence of enterococci to cardiac vegetations as well as to the epithelial cells of the intestine, kidney and urinary tract
［1］. Esp encoded by the chromosomal esp is associated with increased virulence, colonization and persistence in the urinary tract, along with bioﬁlm formation［1, 13,
17, 20, 21］. The production of Cyl has also been shown to signiﬁcantly worsen the severity of endocarditis and endophthalmitis in animal models as well as to contribute to the severity of enterococcal disease in humans［1, 22］.
Cyl is either encoded within pheromone-responsive plas-
mids or on the chromosome within pathogenicity islands and is transcribed as an operon that contains at least 5 genes including cylA［1, 22］. Gel, encoded by the chromosomal gelE, is an extracellular zinc-
metalloprotease that hydrolyzes collagen, gelatin, and small peptides and that has been shown to exacerbate endocarditis in an animal model［1］.
In the present study, we investigated the potential relationships between bioﬁlm formation and clinical impli-
cations of E. faecalis isolates in the urinary tract. Over a 12-year period from 1991 through 2002, a total of 352 E. faecalis isolates were collected from patients with complicated urinary tract infection (UTI)at the urology ward of Okayama University Hospital. We analyzed the prevalence and transferability of genes encoding virulence factors (asa1, esp, cylA, gelE/sprE)and antimicrobial resistance(aac(6’)/aph(2’)). In addition, the production
 
by these isolates of bioﬁlm and extracellular enzymes,
hemolysin(Hln)and Gel was examined, and the associat-
ed medical records of the patients were retrospectively reviewed. The data were summarized in 4 groups based on the presence/absence of asa1 and esp genes encoding enterococcal adhesins, Agg and Esp, respectively.
Materials and Methods
 
The E. faecalis bacterial isolates used in this study were isolated from patients with complicated UTI at the Department of Urology, Okayama University Hospital,
over a 12-year period from 1991 through 2002. A total of 352 isolates that grew to  10?CFU/ml in urinary culture were selected for this study. All 352 patients(one isolate per patient)had documented pyuria(WBC  5/
hpf).
The presence of asa1, esp, cylA gelE/sprE and aac(6’)/aph(2’), which encode Agg, Esp, Cyl, Gel/
serine protease and gentamicin resistance, respectively,
was conﬁrmed by PCR assay. The primers and PCR conditions used in this study are summarized in Table 1.
Multiplex PCR assay was used to detect the asa1 and cylA genes using primers reported by Huycke et al.
［23］. Primers reported by Shankar et al.［20］were used for ampliﬁcation within the N-terminal region of esp.
Primers reported by Nakayama et al.［24］and Van de Klundert et al.［25］were used to amplify gelE/sprE and aac(6’)/aph(2’) genes, respectively. DNA ampliﬁcation was carried out by the method of Kariyama
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Table 1  PCR primers and conditions used in this study
 
Primer speciﬁcity  Primer sequences
 Product length
［bp］
PCR conditions
 
Initial denaturation  Cycling  Cycle
 Final extention
 
Reference
 
asa1  F:5’-GATTCTTCGATTGTGTTGTAAACG-3’R:5’-GGTGCCACAATCAAATTAGG-3’ 380  2 min, 95°C
 1 min, 95°C;1 min,
46°C;1 min, 72°C  35 10 min, 72°C  23 
esp  F:5’-TTGCTAATGCTAGTCCACGACC-3’R:5’-GCGTCAACACTTGCATTGCCGAA-3’ 955  2 min, 95°C
 45 sec, 94°C;45 sec,
63°C;2 min, 72°C  30  7 min, 72°C  20
 
cylA  
F:5’-GGGGATTGATAGGCTTCATCC-3’
R:5’-GCACCGACGGTAATTACAGACTCTAG TCCTCC-3’
432  2 min, 95°C 1 min, 95°C;1 min,46°C;1 min, 72°C  35 10 min, 72°C  23
 
gelE/sprE  F:5’-ATGAAGGGAAATAAAATTTTATAC-3’R:5’-CTGCTGGCACAGCGGATA-3’ 2428  2 min, 94°C
 30 sec, 94°C;30 sec,
48°C;3 min, 72°C  35  6 min, 72°C  24 
aac(6’)/aph(2”) F:5’-CCAAGAGCAATAAGGGCATA-3’R:5’-CACTATCATAACCACTACCG-3’ 220  5 min, 94°C
 1 min, 94°C;1 min,
55°C;1 min, 72°C  35 10 min, 72°C  25
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 et al.［26］. Brieﬂy, total cellular DNA was prepared as follows:0.5 ml of E. faecalis culture, grown overnight in Todd Hewitt broth (Becton Dickinson and Company,
Sparks, MD, USA),was centrifuged, and the pellet was resuspended in 50μl of InstaGene (Bio-Rad Labora-
tories, Hercules, CA, USA). After the suspension was heated for 10 min at 100°C, 2.5μl of the supernatant was mixed with 22.5μl of prepared reaction mixture to start the reaction. The primer pairs were added to the respective reaction mixtures. The 25-μl reaction volume contained 10 mM Tris-HCl(pH 8.3), 50 mM KCl, 1.5 mM MgCl?, 0.2 mM of each deoxynucleotide triphos-
phate(dATP, dCTP, dGTP, and dTTP), and 0.625 U of Taq DNA polymerase(Takara Shuzo, Shiga, Japan).
PCR products were analyzed by electrophoresis on a 2 agarose gel. After electrophoresis, gels were stained with ethidium bromide(1 mg/l)and photographed under a UV trans-illuminator. A 100-bp DNA Ladder(New England Biolabs, Beverly, MA, USA)was used as a molecular size marker. The fragment sizes of PCR products are shown in Table 1.
Production of hemolysin was determined by plating E.
faecalis isolates onto Todd Hewitt agar plates supplement-
ed with 5  rabbit blood and incubated at 37°C for 48 h.
When hemolysis was observed on the plate at 48 h, the isolate was considered a hemolysin-producing isolate.
Production of gelatinase was determined by the method of Su et al.［27］. A transparent halo around colonies after exposure to a solution saturated with ammonium sulfate on the surface of the medium was considered a gelatinase-
positive response.
E. faecalis isolates were grown overnight at 37°C in tryptic soy broth supplemented with 0.25 glucose［15］. The culture was diluted 1:100 in medium, and 200μl of this cell suspen-
sion was used to inoculate sterile ﬂat-bottomed 96-well polystyrene microtiter plates (Corning Inc., Corning,
NY, USA). After 24 h at 37°C without shaking, wells were gently washed three times with 300μl of distilled water, dried in an inverted position, and stained with 300
μl of 2  crystal violet solution in water for 45 min.
After staining, plates were washed 3 times with distilled water. Quantitative analysis of bioﬁlm production was performed by adding 300μl of ethanol-acetic acid(95:5,
vol/vol) to destain the wells. One hundred microliters from each well was transferred to a new microtiter plate,
and the level (optical density;OD) of crystal violet present in the destaining solution was measured at 570 nm using a microtiter plate reader (Seikagaku Co., Tokyo,
Japan). Each assay was performed in triplicate. As a control, uninoculated medium was used to determine background OD. The mean OD??value from the control wells was subtracted from the mean OD??value of tested wells.
Mating experiments were performed by the method of Clewell et al.［28］. Each of 43 E. faecalis isolates possessing the 3 genes asa1, cylA and aac(6’)/aph(2’) was used as donor, and E. faecalis FA2-2 (rifampicin and fusidic acid resistance)was used as recipient. Broth matings were performed with a donor/recipient ratio of 1:10.
Overnight cultures of 0.05 ml of donor and 0.5 ml of recipient were added to 4.5 ml of fresh broth, and the mixtures were incubated at 37°C with gentle agitation for 4 h. Portions (0.1 ml)of the mixed and diluted culture were then plated on Todd Hewitt agar plates with appro-
priate selective antibiotics. Transconjugants were selected on Todd Hewitt agar plates supplemented with 500μg of gentamicin/ml and 25μg of rifampicin and fusidic acid/
ml. Colonies were counted after 48 h of incubation at 37
°C. Separate platings where donors alone were selected provided a basis for estimating the transfer frequency(per donor). Filter matings were also carried out. Overnight cultures of 0.1 ml of donor and 1 ml of recipient were added to 9 ml of fresh broth, and the mixtures were immediately collected on a membrane(25 mm width 0.45
μm pore size ﬁlter, type HA;Millipore Corp., Billerica,
MA, USA), which was inverted onto the surface of a Todd Hewitt agar plate supplemented with 4  horse blood. After incubation at 37°C for 20 h, the cells were suspended in 1 ml of Todd Hewitt broth. The subsequent procedure was the same as that for broth matings.
Transfer frequencies were calculated as the number of transconjugants per donor cell.
We retrospec-
tively reviewed the medical records of the 352 patients whose characteristics were summarized in Table 2 and classiﬁed their UTI as catheter-related or catheter-
unrelated, polymicrobial or monomicrobial, and febrile or non-febrile cases. Febrile UTI was deﬁned as UTI in a patient with a body temperature of 37.0°C.
Data are expressed as mean values± standard deviation(SD). Comparison of OD??values between groups was carried out using
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 Fisher’s exact test or Mann-Whitney’s U test. All results were considered statistically signiﬁcant at the P＜0.05 level.
Results
 
Of the 352 E. faecalis isolates, 291(82.7
), 254(72.2 ), 164(46.6 ), 306(86.9 ), and 141
(40.1 )isolates possessed asa1, esp, cylA, gelE/sprE,
and aac(6’)/aph(2’), respectively. Of 164 isolates pos-
sessing the cylA gene, 63(38.4 )isolates produced Hln.
Of 306 isolates possessing gelE/sprE genes, 167(54.6
)isolates produced Gel. The number of E. faecalis isolates with both asa1 and esp genes, with asa1 gene only,with esp gene only, and with neither gene were 230,
61, 24 and 37, respectively.
Of the 352 E. faecalis isolates, 64(18.2 ), 156(44.3
), and 132(37.5 )isolates exhibited strong(OD??
0.5), medium(OD?? 0.2 to＜0.5), and weak(OD??
0 to＜0.2)bioﬁlm formation, respectively. The mean OD??of the 352 isolates was 0.36±0.37(mean±SD).
We evaluated the relationships between bioﬁlm formation and the 4 virulence determinants of the E. faecalis isolates. As shown in Table 3, the mean OD??value
(mean±SD)was signiﬁcantly higher in asa1-, esp-, and cylA-positive isolates than in asa1-, esp-, and cylA-
negative isolates (P＝0.0176, P＝0.0276 and P＝
0.0116, respectively). The value was also signiﬁcantly higher in Hln producing isolates than in Hln non-
producing isolates (P＝0.0384). We also evaluated the bioﬁlm-forming capacities of E. faecalis isolates in the 4 groups based on the presence/absence of asa1 and esp genes(Fig.1). As shown with a box and whisker plot,
the E. faecalis isolates with asa1 and esp genes had greater capacities for bioﬁlm formation than did those lacking these genes. The Mann-Whitney’s U test of 2 mean OD??values(mean±SD), 0.41±0.42 and 0.22±
0.16, in 230 asa1-, esp-positive and 37 asa1-, esp-
negative isolates, respectively, conﬁrmed that the E.
faecalis isolates possessing both asa1 and esp genes had signiﬁcantly greater capacities for bioﬁlm formation than did those lacking both genes(P＝0.038).
/ /
/
As shown in Fig.2, the percentage of E. faecalis isolates possessing cylA and/or aac(6’)/aph(2’) genes was greatest in the group with both asa1 and esp genes and lower in the groups with only the asa1 gene or the esp gene. No isolates possessing the cylA gene and only 1 isolate possessing the aac(6’)/aph(2’) gene were found in the group lacking both the asa1 and esp genes. In contrast,
E. faecalis isolates possessing gelE/sprE genes were found evenly among the 4 groups. Of the 230 E. faecalis isolates in the group with asa1 and esp genes, 147(63.9
), 195 (84.8 ) and 117 (50.9 ) possessed cylA,
gelE/sprE and aac(6’)/aph(2’)genes, respectively. Of the 61 E. faecalis isolates in the group with only the asa1 gene, 15 (24.6 ), 56 (91.8 ) and 22 (36.1 ) pos-
sessed the cylA, gelE/sprE, and aac(6’)/aph(2’)genes,
respectively. Of the 24 E. faecalis isolates in the group with only the esp gene, 2(8.3 ), 23(95.8 )and 1(4.2
) possessed the cylA, gelE/sprE, and aac(6’)/
aph(2’) genes, respectively. Of the 37 E. faecalis
 
Table 2  Demographic and clinical characteristics of 352 patients with UTI due to E. faecalis
 
Characteristics  Value
 
Age;median±SD(range) 61±20.7(0-94)
Sex;no. male/no. female  240/112
 
Polymicrobial infections  257 isolates Pseudomonas aeruginosa  42 Escherichia coli  28 Methicillin-resistant Staphylococcus aureus  22 Klebsiella pneumoniae  19 Serratia marcescens  17 Staphylococcus epidermidis  13 Citrobacter freundii  13 Staphylococcus aureus  9 Candida albicans  7 Proteus mirabilis  6 Others  81
 
Underlying diseases Bladder cancer  90 Prostatic cancer  49 Other urinary tract cancer  10 Neurogenic bladder  79 Benign prostatic hyperplasia  40 Urinary tract stones  19 Ureteral stricture  7 Ureteropelvic junction stenosis  6 Vesicoureteral reﬂux  5 Others  47
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Table 3  Relationship between bioﬁlm-forming capacities and virulence factors/clinical background
 
Number of isolates  OD??(mean±SD)
P value
(Mann-Whitney’s U test)
Total isolates tested  352  0.36±0.37
 
Virulence determinants asa1-positive  291  0.38±0.38  0.0176 asa1-negative  61  0.27±0.27 esp-positive  254  0.40±0.41  0.0276 esp-negative  98  0.26±0.18 cylA-positive  164  0.41±0.41  0.0116 cylA-negative  188  0.32±0.32 gelE/sprE-positive  306  0.36±0.35  0.0915 gelE/sprE-negative  46  0.35±0.46
 
Extracellular enzymes hemolysin producing  63  0.47±0.48  0.0384 hemolysin non-producing  289  0.34±0.33 gelatinase producing  167  0.35±0.31  0.1376 gelatinase non-producing  185  0.37±0.42
 
Clinical background catheter-related  107  0.33±0.34  0.0582 catheter-unrelated  245  0.38±0.38 polymicrobial  202  0.35±0.34  0.5505 monomicrobial  150  0.37±0.40 febrile  60  0.31±0.32  0.1267 non-febrile  292  0.37±0.38
 
Fig. 1  Bioﬁlm-forming capacities of E. faecalis isolates in 4 groups based on the presence/absence of asa1 and esp genes. OD??
values of the isolates in the 4 groups are shown by the box and whiskers plot, which represents a ﬁve-number summary (upper extreme, upper quartile, median, lower quartile, and lower extreme). The mean OD??values(mean±SD)of the 4 groups are also shown.
?P＝0.038;??P＝0.0449;???P＝0.1208(Mann-Whitney’s U test).
Fig. 2  Percentage of cylA-, gelE/sprE-and aac(6’)/aph(2’)-
positive isolates among E. faecalis isolates in 4 groups based on the presence/absence of asa1 and esp genes.
Bars:…‥…, cylA; , gelE-sprE; , aac(6’)-aph(2’)
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isolates in the group with neither gene, 0(0 ), 32(86.5
)and 1(2.7 )possessed the cylA, gelE/sprE, and aac(6’)/aph(2’) genes, respectively.
/
As shown in Fig. 3, the majority of Hln-
producing and Gel-producing isolates were found in the group with both asa1 and esp genes. Of the 63 Hln-
producing and 167 Gel-producing isolates, 59 (93.7 )
and 94(56.3 )isolates, respectively, possessed both the asa1 and esp genes.
/ To determine the trans-
ferability of asa1, cylA and aac(6’)/aph(2’) genes,
mating experiments were performed. Of the 43 E.
faecalis isolates possessing the 3 genes of asa1, cylA and aac(6’)/aph(2’), 4 isolates were able to donate gentamicin resistance at a frequency of 10??to 10??per donor in broth matings. In ﬁlter matings, 7 of 43 and 28 of 43 isolates were able to donate the gentamicin resis-
tance at a frequency of 10??to 10??and 10??to 10??per donor, respectively. The presence of asa1, cylA and aac(6’)/aph(2’) genes in transconjugants was conﬁrmed
 
by PCR assay. Of the transconjugants from the 35 E.
faecalis isolates possessing asa1, cylA and aac(6’)/
aph(2’), 35 (100 ) possessed the aac(6’)/aph(2’)
gene, 33(94.3 )possessed the asa1 gene and 12(34.3
)possessed the cylA gene.
/
The 352 cases of UTI caused by E. faecalis consisted of 107 catheter-
related(30.4 )and 245 catheter-unrelated(69.6 )cases,
202 polymicrobial(57.4 )and 150 monomicrobial(42.6
)cases, and 60 febrile (17.0 )and 292 non-febrile
(83.0 ) cases. No statistically signiﬁcant diﬀerences between bioﬁlm-forming capacities and clinical background
(catheter-related and catheter-unrelated cases, polymi-
crobial and monomicrobial cases, febrile and non-febrile cases)were found(Table 3). As shown in Fig.4, both asa1 and esp genes were carried by 20, 46, 79 and 85 isolates from patients with catheter-related monomicrobial UTI, catheter-related polymicrobial UTI, catheter-
unrelated monomicrobial UTI and catheter-unrelated polymicrobial UTI, respectively. The asa1 and/or esp genes were carried on 80 of 82(97.6 )and 103 of 124
(83.1 ) isolates from patients with catheter-related
 
Fig.3  Number of E. faecalis isolates producing hemolysin and gelatinase in 4 groups based on the presence/absence of asa1 and esp genes.
Bars:…‥…, hemolysin; , gelatinase
 
Fig.4  Number of E. faecalis isolates in 4 groups based on the presence/absence of asa1 and esp genes. Clinical aspects are shown by 4 categories.
Bars: , catheter-related monomicrobial UTI
, catheter-related polymicrobial UTI
…‥…, catheter-unrelated monomicrobial UTI
, catheter-unrelated polymicrobial UTI
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polymicrobial UTI and catheter-unrelated monomicrobial UTI, respectively, (Fisher’s exact test:P＝0.0020).
Discussion
 
Enterococci are an important cause of nosocomial infections［3-5］. Although E. faecalis in the urinary tract rarely causes serious infectious symptoms, the frequency of isolation of E. faecalis from the urinary tract of hospitalized patients has risen［6-8］. One of the reasons, we suspect, is that the number of patients with various urinary stents and catheters is increasing with the progress of endourology in the urology ward. Therefore,
it is important to understand bioﬁlm formation and the pathogenicity of E. faecalis infections in the urinary tract.
Bioﬁlms are surface-associated, sessile bacterial commu-
nities. A mature bioﬁlm is formed when planktonic cells initially colonize a surface, aggregate and/or grow into multicellular colonies, and embed themselves in an exopolysaccharide matrix［29, 30］. Enterococci have been associated with bioﬁlms on various kinds of indwell-
ing medical devices［29］. An understanding of the bacterial factors that foster enterococci in the nosocomial environment or at infection sites is only recently emerging.
The incidence of virulence factors in E. faecalis clinical isolates has been studied［31-33］. In 1995,
Coque et al.［31］reported that frequencies of Hln, Gel and asa1 in E. faecalis urine isolates were 13, 53 and 67
, respectively. In 2002, Vergis et al.［32］reported that frequencies of Hln, Gel and esp in E. faecalis blood isolates were 11, 64 and 32 , respectively. In our study, frequencies of Hln, Gel, asa1 and esp in E.
faecalis urine isolates were 63/352 (17.9 ), 167/352
(47.4 ), 291/352 (82.7 ) and 254/352 (72.2 ),
respectively. Our data indicated that E. faecalis isolates possessing both asa1 and esp were predominant. As shown in Fig. 2, E. faecalis isolates possessing asa1 were more likely to contain cylA and/or aac(6’)/aph(2’).
This may be due to the expression of asa1-encoded Agg facilitating the subsequent exchange of genetic material between E. faecalis isolates. The additional presence of virulence factors may enhance the ability of pathogenic E.
faecalis to persist in the clinical environment.
Horizontal gene transfer is important for the evolution and genetic diversity of natural microbial communities
［34］. The prevalence of plasmids in bacteria from diverse habitats is well established, and gene transfer by conjugation is one of the best understood mechanisms for
 
dissemination of genetic information. Since most bacteria in natural settings reside within bioﬁlms, it follows that conjugation is a likely mechanism by which bacteria in bioﬁlms transfer genes within or between populations. In this study, we chose E. faecalis isolates possessing the 3 genes asa1, cylA and aac(6’)/aph(2’)to examine gene transfer from one Enterococcus to another. These 3 genes have been reported to be encoded on pheromone-
responsive E. faecalis plasmids［23, 35］. Our data indeed demonstrated the existence of highly conjugative virulence genes and antimicrobial resistance genes in E.
faecalis isolates from patients with UTI.
With regard to bioﬁlm formation, there were contrast-
ing reports on the role of Esp and Gel. A strong correlation between the presence of Esp and the ability of an enterococcal strain to form bioﬁlms in vitro has been reported［13］. In the same study, however, it was suggested that additional determinants in E. faecalis may also contribute to bioﬁlm formation. More recently,
Kristich et al.［14］demonstrated that an esp-negative strain can form bioﬁlms on abiotic surfaces independently of Esp. Mohamed et al.［15］also demonstrated that esp was not required to form bioﬁlm, but that its presence was associated with higher amounts of bioﬁlm. In the same study, several genes of E. faecalis that inﬂuenced primary attachment and bioﬁlm formation (epa, atn,
gelE, and fsr)were identiﬁed. Most recently, Tendolkar et al.［17］deﬁned Esp as a key contributor to the ability of E. faecalis to form bioﬁlms in a glucose-dependent manner. In addition, Kristich et al.［14］reported that Gel enhanced bioﬁlm formation by E. faecalis, whereas Tendolkar et al.［17］did not ﬁnd a synergistic eﬀect between Gel and Esp on bioﬁlm formation. In our study,
bioﬁlm-forming capacities were signiﬁcantly higher in esp-positive isolates than in esp-negative isolates (Table 3). On the other hand, there were no signiﬁcant diﬀerences between gelE/sprE-positive, Gel producing isolates and gelE/sprE-negative, Gel non-producing isolates on bioﬁlm-forming capacities (Table 3).
In our study, cylA-positive, Hln producing E.
faecalis isolates formed bioﬁlms at rates signiﬁcantly higher than those of cylA-negative, Hln non-producing isolates (P＝0.0116 and P＝0.0384, respectively). To our knowledge, there has been no report on Cyl of E.
faecalis implicating it in bioﬁlm formation. Caiazza et al.
［36］showed that Hla, a 34-kDa protein of Staphylococ-
cus aureus that causes host cell lysis by heptamerizing upon insertion into eukaryotic cell membranes, plays a
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primary role in cell-to-cell interactions during bioﬁlm formation. They were initially surprised to ﬁnd that a secreted toxin had such a dramatic impact on bioﬁlm formation. More recently, we showed that the bioﬁlm-
forming capacities of MRSA isolates were higher in hla-
and hlb-positive isolates than in hla-and hlb-negative isolates, respectively［37］. These toxins may be bifun-
ctional enzymes and cause tissue damage of urinary epithelium.
The fsr quorum-sensing system has been shown to regulate 2 proteases, Gel and serine proteases［1, 10-
12］. More recently, Hancock et al.［16］showed that the E. faecalis fsr quorum-sensing system controls bioﬁlm development through the production of Gel.
However, our data do not support this ﬁnding since Gel non-producing isolates can form bioﬁlms(Table 3). In our previous study［24］, a 23.9-kilobase chromosomal dele-
tion containing the fsr gene cluster region was found to be present in the majority of Gel non-producing isolates. An understanding of the process of bioﬁlm formation by E.
faecalis is only now beginning to emerge, and the results appear to be contradictory［38］.
In this study, there were no statistically signiﬁcant diﬀerences between bioﬁlm-forming capacities and clinical background(catheter-related and catheter-unrelated cases,
polymicrobial and monomicrobial cases, febrile and non-
febrile cases). Bioﬁlm formation by enterococci occurs not only with indwelling devices but also in response to any bacterial factor that mediates adherence to compo-
nents of the extracellular matrix of the host［1, 39, 40］.
No single factor predominated as the major predictor of virulence, and their eﬀects appeared to be cumulative
［37］. The relative importance of host factors versus bacterial virulence determinants in disease pathogenesis is unknown. Host factors for E. faecalis disease are likely to include a genetic predisposition via one or more susceptibility genes and acquired factors such as the presence of intravenous devices, surgical wounds, and other events that perturb normal host defenses.
In summary, our study indicates that E. faecalis isolates that have accumulated virulence genes are apt to form persistent bioﬁlms in the urinary tract.
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